JTR-161
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JTR-161, covering 2022-06-30 to 2022-06-30. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR) [Phase 1, Phase 2]